New Developments in Atopic Dermatitis and Implications for the Atopic March
Allergic and Immunologic Skin Diseases
Sunday, March 4, 2018: 10:45 AM-12:00 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Lynda C. Schneider, MD FAAAAI

Learning Objectives:
  1. Discuss the basis of emerging anti-cytokine(anti-TH2, Th22 and Th 17) biologics in the treatment of AD
  2. Discuss other potential therapeutic targets for AD, including JAK inhibitors, PDE4 antagonists, H4R antagonists in AD, and which inflammatory axes are targeted in clinical efficacy and safety data
  3. Discuss new strategies for preventing AD in hgh risk children and their potential role in preventing other atopic manifestations such as food allergies
10:45 AM
Cytokines and Anticytokine Therapies in AD and Other Atopic Diseases
Emma Guttman-Yassky, MD PhD
Recipient of the Hugh A. Sampson Lectureship in Food Allergy: 3rd year
11:00 AM
Question & Answer
11:05 AM
Other Biologics with Potential for Treating AD
Lisa A. Beck, MD FAAAAI
11:20 AM
Question & Answer
11:25 AM
Therapeutic Interventions to Prevent AD and the Atopic March
Donald Y. M. Leung, MD PhD FAAAAI
11:40 AM
Question & Answer
See more of: Session